EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Progress of research on the gut microbiome and its metabolite short-chain fatty acids in postmenopausal osteoporosis: a literature review

Yao Chen, Ying Xie, Xijie Yu

Frontiers of Medicine · 2025-06 · 19 (3) · 474-492

DOI: 10.1007/s11684-025-1129-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers of Medicine, online erschienen am 10.05.2025. Verfasst von Yao Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Endocrinology and Metabolism/Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, 610041, Chin…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fatty Acids, Volatile, Osteoporosis, Postmenopausal. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 192 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postmenopausal osteoporosis (PMOP) is a systemic metabolic bone disease caused by the decrease in estrogen levels after menopause. It leads to bone loss, microstructural damage, and an increased risk of fractures. Studies have found that the gut microbiota and its metabolites can regulate bone metabolism through the gut-bone axis and the gut-brain axis. As research progresses, PMOP has been found to be associated with gut microbiota dysbiosis and Th17/Treg imbalance. The gut microbiota is closely related to the development and differentiation of Treg and Th17 cells. Among them, the metabolites of the gut microbiota such as short-chain fatty acids (SCFAs) can regulate the differentiation of effector T cells by acting on molecular receptors on immune cells, thereby regulating the bone immune process. The multifaceted relationship among the gut microbiota, SCFAs, Th17/Treg cell-mediated bone immunity, and bone metabolism is eliciting attention from researchers. Through a review of existing literature, we have comprehensively summarized the effects of the gut microbiota and SCFAs on PMOP, especially from the perspective of Th17/Treg balance. Regulating this balance may provide new opportunities for PMOP treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeFatty Acids, VolatileOsteoporosis, PostmenopausalHumansFemaleT-Lymphocytes, RegulatoryTh17 CellsDysbiosisBone and Bones

Stichwörter der Autor:innen

Th17 cellsTreg cellsgut microbiotapostmenopausal osteoporosisshort-chain fatty acids

Substanzen

Fatty Acids, Volatile

Autor:innen und Institutionen

  • Laboratory of Endocrinology and Metabolism/Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Department of Internal Medicine, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, 610041, China.
  • Laboratory of Endocrinology and Metabolism/Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, 610041, China. xijieyu@hotmail.com.

Zitieren

APA

Chen, Y., Xie, Y., & Yu, X. (2025). Progress of research on the gut microbiome and its metabolite short-chain fatty acids in postmenopausal osteoporosis: a literature review. Frontiers of Medicine, 19(3), 474-492. https://doi.org/10.1007/s11684-025-1129-3

Vancouver

Chen Y, Xie Y, Yu X. Progress of research on the gut microbiome and its metabolite short-chain fatty acids in postmenopausal osteoporosis: a literature review. Frontiers of Medicine. 2025;19(3):474-492. doi:10.1007/s11684-025-1129-3

BibTeX
@article{Chen2025,
  author = {Chen, Yao and Xie, Ying and Yu, Xijie},
  title = {Progress of research on the gut microbiome and its metabolite short-chain fatty acids in postmenopausal osteoporosis: a literature review},
  journal = {Frontiers of Medicine},
  year = {2025},
  volume = {19},
  number = {3},
  pages = {474--492},
  doi = {10.1007/s11684-025-1129-3}
}
Kostenlos starten →